Table 1.

Hematologic Parameters, Transfusion Requirement, and Two-Color Flow Cytometric Analysis of DAF and CD59/MACIF Expression by Erythrocytes in Nine PNH Patients

Case No.Age/SexHb (g/dL)Reticulocytes (%)Bone Marrow Cellularity (× 104/μL)Transfusion Requirement*Two-Color Analysis (%)
PositiveIntermediateNegative
1 50/M 9.2 2.6 25.0 None 66.0 ND 33.8 
65/M 15.1 2.6 19.2 None 35.1 ND 64.4 
61/M 8.8 2.5 5.0 None 88.9 ND 10.9 
4 24/F 5.4 0.2 0.8 Frequent 98.1 ND 1.6 
20/M 11.4 2.6 10.0 None 88.8 ND 10.7 
58/M 6.7 6.8 11.0 None 54.9 ND 45.0 
77/M 5.5 2.4 3.1 None ND 78.1 21.8 
24/F 6.3 7.6 34.7 None 5.4 78.6 15.9 
38/F 8.8 10.4 2.3 None ND ND 95.0 
Case No.Age/SexHb (g/dL)Reticulocytes (%)Bone Marrow Cellularity (× 104/μL)Transfusion Requirement*Two-Color Analysis (%)
PositiveIntermediateNegative
1 50/M 9.2 2.6 25.0 None 66.0 ND 33.8 
65/M 15.1 2.6 19.2 None 35.1 ND 64.4 
61/M 8.8 2.5 5.0 None 88.9 ND 10.9 
4 24/F 5.4 0.2 0.8 Frequent 98.1 ND 1.6 
20/M 11.4 2.6 10.0 None 88.8 ND 10.7 
58/M 6.7 6.8 11.0 None 54.9 ND 45.0 
77/M 5.5 2.4 3.1 None ND 78.1 21.8 
24/F 6.3 7.6 34.7 None 5.4 78.6 15.9 
38/F 8.8 10.4 2.3 None ND ND 95.0 

Abbreviations: Hb, hemoglobin; ND, not detectable.

*

The transfusion requirement was judged from the history of transfusion in the 12-month period before each experiment.

Aplastic anemia progressed to PNH.

Close Modal

or Create an Account

Close Modal
Close Modal